Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the 
NS3/4A Protease Inhibitor Telaprevir

Susser, Simone; Flinders, Mathieu; Reesink, Henk W.; Zeuzem, Stefan; Lawyer, Glenn; Ghys, Anne; Van Eygen, Veerle; Witek, James; De Meyer, Sandra; Sarrazin, Christoph

doi:10.1128/AAC.04911-14

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir

MPS-Authors

/persons/resource/persons79265

Flinders, Mathieu
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

/persons/resource/persons44895

Lawyer, Glenn
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Susser, S., Flinders, M., Reesink, H. W., Zeuzem, S., Lawyer, G., Ghys, A., et al. (2015). Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir. Antimicrobial Agents and Chemotherapy, 59(5), 2746-2755. doi:10.1128/AAC.04911-14.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0028-1345-A

Abstract

There is no abstract available